Bank Of America Corp Crispr Therapeutics Ag Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

A detailed history of Bank Of America Corp transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Bank Of America Corp holds 1,448,415 shares of CRSP stock, worth $82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,448,415
Previous 1,386,770 4.45%
Holding current value
$82 Million
Previous $47.2 Million 49.29%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$31.27 - $48.64 $1.93 Million - $3 Million
61,645 Added 4.45%
1,448,415 $70.5 Million
Q1 2025

May 15, 2025
BUY
$34.03 - $53.02 $5.96 Million - $9.29 Million
175,261 Added 14.47%
1,386,770 $47.2 Million
Q4 2024

Feb 14, 2025
BUY
$38.65 - $55.15 $5.01 Million - $7.16 Million
129,746 Added 11.99%
1,211,509 $47.7 Million
Q3 2024

Nov 14, 2024
BUY
$44.62 - $62.75 $6.26 Million - $8.8 Million
140,213 Added 14.89%
1,081,763 $50.8 Million
Q2 2024

Aug 14, 2024
BUY
$51.17 - $68.18 $4.01 Million - $5.34 Million
78,336 Added 9.07%
941,550 $50.9 Million
Q1 2024

May 15, 2024
BUY
$60.67 - $89.12 $10.4 Million - $15.3 Million
172,044 Added 24.89%
863,214 $58.8 Million
Q4 2023

Feb 14, 2024
SELL
$38.62 - $72.18 $2.45 Million - $4.58 Million
-63,387 Reduced 8.4%
691,170 $43.3 Million
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $10.3 Million - $16.1 Million
236,851 Added 45.75%
754,557 $42.4 Million
Q1 2023

May 12, 2023
BUY
$41.0 - $56.12 $3.74 Million - $5.12 Million
91,190 Added 21.38%
517,706 $23.4 Million
Q4 2022

Feb 10, 2023
SELL
$39.19 - $65.67 $40.9 Million - $68.6 Million
-1,044,166 Reduced 71.0%
426,516 $17.3 Million
Q3 2022

Nov 14, 2022
BUY
$61.1 - $83.78 $14.9 Million - $20.4 Million
243,970 Added 19.89%
1,470,682 $96.1 Million
Q2 2022

Aug 12, 2022
BUY
$43.23 - $73.83 $21.6 Million - $37 Million
500,763 Added 68.98%
1,226,712 $74.5 Million
Q1 2022

May 16, 2022
BUY
$53.19 - $79.24 $13.9 Million - $20.7 Million
260,739 Added 56.05%
725,949 $45.6 Million
Q4 2021

Feb 08, 2022
SELL
$70.09 - $111.29 $26.3 Million - $41.7 Million
-374,563 Reduced 44.6%
465,210 $35.3 Million
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $28.3 Million - $40.2 Million
256,875 Added 44.07%
839,773 $94 Million
Q2 2021

Sep 13, 2021
BUY
$100.84 - $161.89 $58.8 Million - $94.4 Million
582,898 New
582,898 $94.4 Million

Others Institutions Holding CRSP

# of Institutions
525
Shares Held
69.6M
Call Options Held
3.72M
Put Options Held
2.33M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.42B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email